Doctor Espresso Limited 06171278 false 2023-04-01 2024-03-31 2024-03-31 The principal activity of the company is that of coffee outlets. Digita Accounts Production Advanced 6.30.9574.0 true true 06171278 2023-04-01 2024-03-31 06171278 2024-03-31 06171278 bus:Director1 1 2024-03-31 06171278 bus:OrdinaryShareClass1 2024-03-31 06171278 core:CurrentFinancialInstruments 2024-03-31 06171278 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 06171278 core:Non-currentFinancialInstruments 2024-03-31 06171278 core:Non-currentFinancialInstruments core:AfterOneYear 2024-03-31 06171278 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2024-03-31 06171278 core:Goodwill 2024-03-31 06171278 core:FurnitureFittingsToolsEquipment 2024-03-31 06171278 core:LandBuildings 2024-03-31 06171278 core:MotorVehicles 2024-03-31 06171278 core:OtherPropertyPlantEquipment 2024-03-31 06171278 bus:SmallEntities 2023-04-01 2024-03-31 06171278 bus:AuditExemptWithAccountantsReport 2023-04-01 2024-03-31 06171278 bus:FullAccounts 2023-04-01 2024-03-31 06171278 bus:SmallCompaniesRegimeForAccounts 2023-04-01 2024-03-31 06171278 bus:RegisteredOffice 2023-04-01 2024-03-31 06171278 bus:Director1 2023-04-01 2024-03-31 06171278 bus:Director1 1 2023-04-01 2024-03-31 06171278 bus:OrdinaryShareClass1 2023-04-01 2024-03-31 06171278 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 06171278 core:ComputerSoftware 2023-04-01 2024-03-31 06171278 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2023-04-01 2024-03-31 06171278 core:Goodwill 2023-04-01 2024-03-31 06171278 core:FurnitureFittings 2023-04-01 2024-03-31 06171278 core:FurnitureFittingsToolsEquipment 2023-04-01 2024-03-31 06171278 core:LandBuildings 2023-04-01 2024-03-31 06171278 core:LeaseholdImprovements 2023-04-01 2024-03-31 06171278 core:MotorVehicles 2023-04-01 2024-03-31 06171278 core:OfficeEquipment 2023-04-01 2024-03-31 06171278 core:OtherPropertyPlantEquipment 2023-04-01 2024-03-31 06171278 core:PlantMachinery 2023-04-01 2024-03-31 06171278 core:OtherRelatedParties 2023-04-01 2024-03-31 06171278 countries:AllCountries 2023-04-01 2024-03-31 06171278 2023-03-31 06171278 bus:Director1 1 2023-03-31 06171278 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2023-03-31 06171278 core:Goodwill 2023-03-31 06171278 core:FurnitureFittingsToolsEquipment 2023-03-31 06171278 core:LandBuildings 2023-03-31 06171278 core:MotorVehicles 2023-03-31 06171278 core:OtherPropertyPlantEquipment 2023-03-31 06171278 2022-04-01 2023-03-31 06171278 2023-03-31 06171278 bus:Director1 1 2023-03-31 06171278 bus:OrdinaryShareClass1 2023-03-31 06171278 core:CurrentFinancialInstruments 2023-03-31 06171278 core:CurrentFinancialInstruments core:WithinOneYear 2023-03-31 06171278 core:Non-currentFinancialInstruments 2023-03-31 06171278 core:Non-currentFinancialInstruments core:AfterOneYear 2023-03-31 06171278 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2023-03-31 06171278 core:Goodwill 2023-03-31 06171278 core:FurnitureFittingsToolsEquipment 2023-03-31 06171278 core:LandBuildings 2023-03-31 06171278 core:MotorVehicles 2023-03-31 06171278 core:OtherPropertyPlantEquipment 2023-03-31 06171278 bus:Director1 1 2022-04-01 2023-03-31 06171278 bus:Director1 1 2022-03-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 06171278

Doctor Espresso Limited

Unaudited Filleted Financial Statements

for the Year Ended 31 March 2024

 

Doctor Espresso Limited

Contents

Company Information

1

Statement of Director's Responsibilities

2

Balance Sheet

3

Notes to the Unaudited Financial Statements

4 to 11

 

Doctor Espresso Limited

Company Information

Director

Ms Vanessa Lancellotti

Registered office

88 Peterborough Road
London
SW6 3HH

Accountants

Michaelides Warner & Co
102 Fulham Palace Road
London
W6 9PL

 

Doctor Espresso Limited

Statement of Director's Responsibilities

Company law requires the director to prepare financial statements for each financial year. Under that law the director has elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law), including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' . Under company law the director must not approve the financial statements unless she is satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the director is required to:

select suitable accounting policies and apply them consistently;

make judgements and accounting estimates that are reasonable and prudent;

prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The director is responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable her to ensure that the financial statements comply with the Companies Act 2006. She is also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

 

Doctor Espresso Limited

(Registration number: 06171278)
Balance Sheet as at 31 March 2024

Note

2024
£

2023
£

Fixed assets

 

Intangible assets

4

6,600

7,080

Tangible assets

5

12,151

12,193

 

18,751

19,273

Current assets

 

Stocks

6

3,235

5,391

Debtors

7

88,415

59,037

Cash at bank and in hand

 

44,682

102,382

 

136,332

166,810

Creditors: Amounts falling due within one year

8

(150,952)

(137,028)

Net current (liabilities)/assets

 

(14,620)

29,782

Total assets less current liabilities

 

4,131

49,055

Creditors: Amounts falling due after more than one year

8

(31,854)

(34,404)

Net (liabilities)/assets

 

(27,723)

14,651

Capital and reserves

 

Called up share capital

9

2

2

Retained earnings

(27,725)

14,649

Shareholders' (deficit)/funds

 

(27,723)

14,651

For the financial year ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

Approved and authorised by the director on 10 January 2025
 

.........................................
Ms Vanessa Lancellotti
Director

   
     
 

Doctor Espresso Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2024

1

General information

The company is a private company limited by share capital, incorporated in England & Wales .

The address of its registered office is:
88 Peterborough Road
London
SW6 3HH
England

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis.

Judgements

The directors consider that there are no key judgements that management have made in the process of applying the company's accounting policies and that may have had a significant effect on the amounts recognised in the financial statements.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when the amount of revenue can be reliably measured, it is probable that future economic benefits will flow to the entity and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

 

Doctor Espresso Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2024

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Motor vehicles

25% Reducing balance

Fixtures and fittings

25% Reducing balance, and Straight line method

Plant and machinery

25% Reducing balance, and Straight line method

Office equipment

25% Straight line

Leasehold improvements

Straight line over 20 years

Goodwill

Goodwill arising on the acquisition of an entity represents the excess of the cost of acquisition over the company’s interest in the net fair value of the identifiable assets, liabilities and contingent liabilities of the entity recognised at the date of acquisition. Goodwill is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is held in the currency of the acquired entity and revalued to the closing rate at each reporting period date. Goodwill is amortised over its useful life, which shall not exceed ten years if a reliable estimate of the useful life cannot be made.

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Asset class

Amortisation method and rate

Website domain

12.5% Straight line

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

 

Doctor Espresso Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2024

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

 

Doctor Espresso Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2024

Financial instruments

Classification
The company only enters into basic financial instruments transactions that result in the recognition of financial assets and liabilities like investments, trade and other receivables,cash and bank balances, trade and other creditors.

Debt instruments that are payable or receivable within one year, typically trade debtors and creditors, are measured, initially and subsequently, at the undiscounted amount of the cash or cash consolidation expected to be paid or received.

 

3

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 13 (2023 - 14).

4

Intangible assets

Goodwill
 £

Internally generated software development costs
 £

Total
£

Cost or valuation

At 1 April 2023

8,040

120

8,160

At 31 March 2024

8,040

120

8,160

Amortisation

At 1 April 2023

960

120

1,080

Amortisation charge

480

-

480

At 31 March 2024

1,440

120

1,560

Carrying amount

At 31 March 2024

6,600

-

6,600

At 31 March 2023

7,080

-

7,080

 

Doctor Espresso Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2024

5

Tangible assets

Land and buildings
£

Furniture, fittings and equipment
 £

Motor vehicles
 £

Other tangible assets
£

Cost or valuation

At 1 April 2023

20,000

1,952

1,200

5,663

Additions

-

-

-

3,810

At 31 March 2024

20,000

1,952

1,200

9,473

Depreciation

At 1 April 2023

10,000

1,178

1,200

4,244

Charge for the year

1,000

487

-

2,365

At 31 March 2024

11,000

1,665

1,200

6,609

Carrying amount

At 31 March 2024

9,000

287

-

2,864

At 31 March 2023

10,000

774

-

1,419

Total
£

Cost or valuation

At 1 April 2023

28,815

Additions

3,810

At 31 March 2024

32,625

Depreciation

At 1 April 2023

16,622

Charge for the year

3,852

At 31 March 2024

20,474

Carrying amount

At 31 March 2024

12,151

At 31 March 2023

12,193

Included within the net book value of land and buildings above is £9,000 (2023 - £10,000) in respect of short leasehold land and buildings.
 

 

Doctor Espresso Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2024

6

Stocks

2024
£

2023
£

Other inventories

3,235

5,391

7

Debtors

2024
£

2023
£

Trade debtors

446

-

Prepayments

11,246

11,245

Other debtors

76,723

47,792

88,415

59,037

 

Doctor Espresso Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2024

8

Creditors

Creditors: amounts falling due within one year

Note

2024
£

2023
£

Due within one year

 

Loans and borrowings

10

16,913

15,840

Trade creditors

 

45,795

40,321

Taxation and social security

 

15,502

15,035

Accruals and deferred income

 

1,600

4,410

Other creditors

 

71,142

61,422

 

150,952

137,028

Creditors: amounts falling due after more than one year

Note

2024
£

2023
£

Due after one year

 

Loans and borrowings

10

31,854

34,404

9

Share capital

Allotted, called up and fully paid shares

 

2024

2023

 

No.

£

No.

£

Ordinary of £1 each

2

2

2

2

         

10

Loans and borrowings

2024
£

2023
£

Non-current loans and borrowings

Bank borrowings

31,854

34,404

 

Doctor Espresso Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2024

2024
£

2023
£

Current loans and borrowings

Bank borrowings

6,219

6,218

Bank overdrafts

10,694

9,622

16,913

15,840

11

Related party transactions

2024

At 1 April 2023
£

Advances to director
£

At 31 March 2024
£

Ms Vanessa Lancellotti

Amount owed to Director

38,920

523

39,442

       
     

 

2023

At 1 April 2022
£

Advances to director
£

At 31 March 2023
£

Ms Vanessa Lancellotti

Amount owed to Director

58,204

(19,284)

38,920

       
     

 

Summary of transactions with other related parties

Included in other debtors is an loan of £64,335 (2023 £35,404) owed by Doctor R Espresso Limited.